BioMarin Pharmaceutical, Inc. (BMRN)
55.41
-0.18
(-0.32%)
USD |
NASDAQ |
Mar 26, 09:39
BioMarin Pharmaceutical Cash from Investing (Quarterly) : -42.45M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | -6.494M |
| Ionis Pharmaceuticals, Inc. | -419.50M |
| Mirum Pharmaceuticals, Inc. | 1.006M |
| MannKind Corp. | -291.96M |
| Terns Pharmaceuticals, Inc. | 24.50M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 99.64M |
| Cash from Financing (Quarterly) | 3.157M |
| Free Cash Flow | 717.02M |
| Free Cash Flow Per Share (Quarterly) | 0.2942 |
| Free Cash Flow to Equity (Quarterly) | 24.87M |
| Free Cash Flow to Firm (Quarterly) | 61.32M |
| Free Cash Flow Yield | 6.65% |